MR编号 | PT/H/0985/004 |
---|
药品名称 | Amoxicilina + Ácido Clavulânico Kabi |
---|
活性成分 | - amoxicillin sodium salt 2000.0 mg
- clavulanic acid potassium salt 200.0 mg
|
---|
剂型 | Powder for solution for injection |
---|
上市许可持有人 | Fresenius Kabi Pharma Portugal, Lda. |
---|
参考成员国 - 产品名称 | Portugal (PT) |
---|
互认成员国 - 产品名称 | - Germany (DE)
Amoicillin/Clavulanic acid Kabi 2000 mg/200mg Pulver zur Herstellung einer Infusionslösung - Belgium (BE)
Amoxiclav Fresenius Kabi 2000 mg/200 mg poeder voor oplossing voor infusie - Netherlands (NL)
- Luxembourg (LU)
- France (FR)
- Spain (ES)
- Italy (IT)
- Poland (PL)
Amoxicillin/Clavuclanic Acid Kabi - Hungary (HU)
AMOXICILLIN/KLAVULÁNSAV KABI 2000 mg/200 mg por oldatos infúzióhoz
|
---|
许可日期 | 2014/01/09 |
---|
最近更新日期 | 2024/04/02 |
---|
药物ATC编码 | - J01CR02 amoxicillin and beta-lactamase inhibitor
|
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|